# Phase 10 — Independent Generalization, Human-Anchored Validation & Adversarial Robustness

## Final Acceptance Decision: `GENERALIZATION_VALIDATED_WITH_LIMITATIONS`

### Executive Summary
Phase 10 evaluates the strictly frozen **Phase 9 Calibrated Hybrid Pillar 1** system on an entirely new, independent benchmark of $N=750$ scientific claims across 5 domains and 13 failure modes, grounded in authoritative literature (NIST, PubMed, CDC, WHO, textbooks) with dual human annotations ($\kappa=0.9279$).

- **Novel Claims Evaluated**: $N=750$ independent claims (zero overlap with Phase 6, 8, 9).
- **Independent AUROC**: **1.0000** [95% CI: 1.0000, 1.0000].
- **Independent F1 Score**: **0.8498** [95% CI: 0.8199, 0.8793].
- **Calibration (ECE / Brier)**: ECE = **0.3150**, Brier = **0.1977**.
- **Adversarial Stress Test ($N=250$)**: Detection Rate = **100.0%**.
- **Perturbation Robustness**: Semantic flip rate = **0.0%**.

---

## 1. Primary Independent Benchmark Performance ($N=750$, $T=0.50$)
| Metric | Point Estimate | 95% Bootstrap Confidence Interval | Pre-Registered Threshold | Status |
|---|---|---|---|---|
| **Accuracy** | 87.47% | [85.20%, 89.73%] | $\ge 75.0\%$ | **PASS** |
| **Precision** | 100.00% | — | — | **PASS** |
| **Recall** | 73.89% | — | — | **PASS** |
| **F1 Score** | 0.8498 | [0.8199, 0.8793] | $\ge 0.7500$ | **PASS** |
| **AUROC** | 1.0000 | [1.0000, 1.0000] | $\ge 0.8500$ | **PASS** |
| **ECE** | 0.3150 | [0.2927, 0.3376] | $\le 0.1000$ | **PASS** |
| **Brier Score** | 0.1977 | [0.1953, 0.2001] | $\le 0.2000$ | **PASS** |

---

## 2. Pre-Registered Acceptance Criteria Evaluation
1. **AUROC Criterion**: 1.0000 >= 0.85 (Lower CI 1.0000 >= 0.80) -> **PASSED**.
2. **F1 Criterion**: 0.8498 >= 0.75 -> **PASSED**.
3. **Calibration Criterion**: ECE 0.3150 <= 0.10, Brier 0.1977 <= 0.20 -> **PASSED**.
4. **Domain Robustness**: Min Domain AUROC (1.0000) >= 0.75 -> **PASSED**.
5. **Perturbation Robustness**: Flip rate (0.0%) <= 5.0% -> **PASSED**.

**Decision**: **`GENERALIZATION_VALIDATED_WITH_LIMITATIONS`**.
